1.Erythrocyte Membrane Protein Alterations by SDS-PAGE and Underlying Clinical Heterogeneity in Hereditary Spherocytosis.
Eun Sun YOO ; Hyoung Soo CHOI ; Hee Young SHIN ; Hyo Seop AHN ; Young Kyung LEE ; Han Ik CHO
Korean Journal of Pediatric Hematology-Oncology 1997;4(2):261-272
BACKGROUND: Hereditary spherocytosis(HS) is a clinically and biochemically very heterogeneous disorder The purpose of this study is to detect erythrocyte membrane protein abnormalities by SDS-PAGE and to investigate the frequency of erythrocyte membrane protein defects in hereditary spherocytosis and correlation between some of the hereditary spherocytosis biochemical subsets and the selected clinical phenotype. METHODS: We evaluated the clinical and laboratory characteristics of 14 normal healthy persons and 23 hereditary spherocytosis patients and 8 their family members. The patients were divided into three groups based on clinical and hematological severity(mild, typical, severe). In addition to routine hematologic determlnatlons, osmotic fragility and autohemolysis, RBC membrane protein analysis were performed in all patients by densitometric tracing of SDS-PAGE(sodium dodecyl sulphate polyacrylamide gel electrophoresis) stained by Coomassle blue utilizing both the discontinuous buffer system of Laemmli with acrylamide linear gradient from 4% to 12% and the continuous buffer system of Fairbank with exponential gradient of acrylamide from 3.5% to 17%. RESULTS: 1) The patients could be seperated into three classes of different clinical severity as mild(3 cases), moderate(16 cases) and severe(4 cases) on the clinical feature. 2) Eighteen patients(82.6%) among 23 hereditary spherocytosis revealed abnormal erythrocyte membrane protein and we detected six patients(26.1%) with spectrin deficiency combined with ankyrin reduction, 4 patients(17.4%) with ankyrin deficiency, 4 patients(17.4%) with isolated spectrin deficiency and 3 patients(13.0%) with band 3 deficiency. Five HS patients(21.7%) showed normal RBC membrane protein. 3) Eight HS and their family members showed same RBC membrane protein deficiency. 4) The type and degree of RBC membrane protein reduction were variale with spectrin at 66~94%, with ankyrin at 48~82% of normal levels. These showed that each patient had different clinical severities according to different RBC membrane protein levels and type. CONCLUSION: RBC membrane protein abnormalities were observed in 82.6% of HS patients. The combined spectrin and ankyrin deficiency is the most common molecular defect in HS. The clinical severity and biochemical expression is heterogeneous. SDS-PAGE analysis of RBC membrane protein was provided the diagnosis of RBC membrane defects and basic molecular studies. We believed that the early identification of the biochemical defect responsible for HS is important because it is helpful starling point for the identification of the primary molecular defect, and it could help to anticipate the clinical outcome of the disease. For these reasons, we consider the SDS-PAGE of the red cell membrane to be of crucial importance for a complete evaluation of children with HS. Further studies with more cases would be to clarify the correlation between clinical and biochemical phenotypes.
Acrylamide
;
Ankyrins
;
Cell Membrane
;
Child
;
Diagnosis
;
Electrophoresis, Polyacrylamide Gel*
;
Erythrocyte Membrane*
;
Erythrocytes*
;
Erythrocytes, Abnormal
;
Humans
;
Membrane Proteins
;
Membranes
;
Osmotic Fragility
;
Phenotype
;
Population Characteristics*
;
Spectrin
;
Starlings
2.Hereditary Spherocytosis
Clinical Pediatric Hematology-Oncology 2012;19(2):57-63
Hereditary spherocytosis is a hemolytic anemia caused by erythrocyte membrane deficiencies that lead to membrane destabilization and vesiculation. Abnormal spherocytes are trapped and destroyed in the spleen. Mutations in several genes, SPTA1, SPTB, ANK1, SLCA1 and EPB42 cause alpha-spectrin, beta-spectrin, ankyrin, band 3 or protein 4.2 protein deficiencies, respectively. The clinical severity ranged from asymptomatic to severe hemolytic anemia requiring erythrocyte transfusion. Common complications are cholelithiasis, hemolytic episodes and aplastic crises. Till now, splenectomy is considered as only curative method in this genetic disorder. However, in the future, molecular analysis will make elucidate the genotype-phenotype interactions and can innovate to modify treatment strategies.
Anemia, Hemolytic
;
Ankyrins
;
Cholelithiasis
;
Erythrocyte Membrane
;
Erythrocyte Transfusion
;
Erythrocytes
;
Membranes
;
Protein Deficiency
;
Spectrin
;
Spherocytes
;
Spherocytosis, Hereditary
;
Spleen
;
Splenectomy
3.Sodium and calcium transport in spherocytic red blood cells.
Shin Heh KANG ; Kir Young KIM ; Young Ho LEE ; Bok Soon KANG
Journal of the Korean Pediatric Society 1991;34(7):978-991
No abstract available.
Calcium*
;
Erythrocytes*
;
Sodium*
;
Spherocytes
4.Morphologic changes and morphology score of red blood cells stored in CPDA-1.
Sung Hee LEE ; Tae Youn CHOI ; Won Bae KIM ; Duk Yong KANG ; Young Chul OH
Korean Journal of Blood Transfusion 1993;4(1):49-53
No abstract available.
Erythrocytes*
5.Preparation and post-transfusion aurvial of frozen-deglycerolized red blood cells.
Kyou Sup HAN ; Seog Woon KWON ; Bok Yun HAN ; Sang In KIM ; Young Chul OH ; Bum Ryoul CHOI ; Ki Hong KIM ; Noel R WEBSTER ; Luke S CHUNG ; James J JAMES
Korean Journal of Blood Transfusion 1992;3(1):1-7
No abstract available.
Erythrocytes*
8.Post-transfusion survival of acid-B preserved red blood cells.
Kyou Sup HAN ; Seong Woon KWON ; Sang In KIM ; Young Chul OH ; Bum Ryoul CHOI
Korean Journal of Blood Transfusion 1991;2(1):57-61
No abstract available.
Erythrocytes*
9.Preparation of frozen-deglycerolized red blood cells (I).
Kyou Sup HAN ; Hee Jung KANG ; Bok Yun HAN ; Sang In KIM ; Young Chul OH ; Bum Ryoul CHOI ; Ki Hong KIM ; Noel R WEBSTER ; Luke S CHUNG ; James J JAMES
Korean Journal of Blood Transfusion 1991;2(1):43-49
No abstract available.
Erythrocytes*
10.The vreference ranges and clinical usefulness of "free erythrocyte protoporphrin" test.
Jeong Ho KIM ; Q Eun PARK ; Oh Hun KWON
Korean Journal of Clinical Pathology 1993;13(1):13-18
No abstract available.
Erythrocytes*